vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Chemours Co (CC). Click either name above to swap in a different company.
Chemours Co is the larger business by last-quarter revenue ($1.3B vs $821.5M, roughly 1.6× Acadia Healthcare Company, Inc.). Chemours Co runs the higher net margin — -3.5% vs -143.3%, a 139.8% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (6.1% vs -2.1%). Chemours Co produced more free cash flow last quarter ($92.0M vs $-179.5M). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (3.4% CAGR vs -1.2%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.
ACHC vs CC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $821.5M | $1.3B |
| Net Profit | $-1.2B | $-47.0M |
| Gross Margin | — | 11.7% |
| Operating Margin | -142.4% | — |
| Net Margin | -143.3% | -3.5% |
| Revenue YoY | 6.1% | -2.1% |
| Net Profit YoY | -3710.4% | -261.5% |
| EPS (diluted) | $-12.98 | $-0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $821.5M | $1.3B | ||
| Q3 25 | $851.6M | $1.5B | ||
| Q2 25 | $869.2M | $1.6B | ||
| Q1 25 | $770.5M | $1.4B | ||
| Q4 24 | $774.2M | $1.4B | ||
| Q3 24 | $815.6M | $1.5B | ||
| Q2 24 | $796.0M | $1.6B | ||
| Q1 24 | $768.1M | $1.4B |
| Q4 25 | $-1.2B | $-47.0M | ||
| Q3 25 | $36.2M | $46.0M | ||
| Q2 25 | $30.1M | $-380.0M | ||
| Q1 25 | $8.4M | $-5.0M | ||
| Q4 24 | $32.6M | $-13.0M | ||
| Q3 24 | $68.1M | $-32.0M | ||
| Q2 24 | $78.5M | $60.0M | ||
| Q1 24 | $76.4M | $54.0M |
| Q4 25 | — | 11.7% | ||
| Q3 25 | — | 15.6% | ||
| Q2 25 | — | 17.2% | ||
| Q1 25 | — | 17.3% | ||
| Q4 24 | — | 19.4% | ||
| Q3 24 | — | 19.0% | ||
| Q2 24 | — | 19.8% | ||
| Q1 24 | — | 20.9% |
| Q4 25 | -142.4% | — | ||
| Q3 25 | 4.7% | 2.5% | ||
| Q2 25 | 5.8% | -15.4% | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 4.9% | -0.1% | ||
| Q3 24 | 12.1% | -2.1% | ||
| Q2 24 | 13.4% | 4.4% | ||
| Q1 24 | 12.9% | 5.1% |
| Q4 25 | -143.3% | -3.5% | ||
| Q3 25 | 4.3% | 3.1% | ||
| Q2 25 | 3.5% | -23.5% | ||
| Q1 25 | 1.1% | -0.4% | ||
| Q4 24 | 4.2% | -1.0% | ||
| Q3 24 | 8.4% | -2.1% | ||
| Q2 24 | 9.9% | 3.9% | ||
| Q1 24 | 9.9% | 4.0% |
| Q4 25 | $-12.98 | $-0.32 | ||
| Q3 25 | $0.40 | $0.31 | ||
| Q2 25 | $0.33 | $-2.53 | ||
| Q1 25 | $0.09 | $-0.03 | ||
| Q4 24 | $0.36 | $-0.07 | ||
| Q3 24 | $0.74 | $-0.22 | ||
| Q2 24 | $0.85 | $0.39 | ||
| Q1 24 | $0.83 | $0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.2M | $670.0M |
| Total DebtLower is stronger | $2.5B | $4.1B |
| Stockholders' EquityBook value | $1.9B | $250.0M |
| Total Assets | $5.5B | $7.4B |
| Debt / EquityLower = less leverage | 1.28× | 16.40× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.2M | $670.0M | ||
| Q3 25 | $118.7M | $613.0M | ||
| Q2 25 | $131.4M | $502.0M | ||
| Q1 25 | $91.2M | $464.0M | ||
| Q4 24 | $76.3M | $713.0M | ||
| Q3 24 | $82.1M | $596.0M | ||
| Q2 24 | $77.2M | $604.0M | ||
| Q1 24 | $77.3M | $746.0M |
| Q4 25 | $2.5B | $4.1B | ||
| Q3 25 | $2.3B | $4.1B | ||
| Q2 25 | $2.3B | $4.1B | ||
| Q1 25 | $2.2B | $4.1B | ||
| Q4 24 | $2.0B | $4.1B | ||
| Q3 24 | $1.9B | $4.0B | ||
| Q2 24 | $1.8B | $4.0B | ||
| Q1 24 | $1.9B | $4.0B |
| Q4 25 | $1.9B | $250.0M | ||
| Q3 25 | $3.1B | $274.0M | ||
| Q2 25 | $3.1B | $228.0M | ||
| Q1 25 | $3.0B | $566.0M | ||
| Q4 24 | $3.1B | $571.0M | ||
| Q3 24 | $3.0B | $643.0M | ||
| Q2 24 | $3.0B | $714.0M | ||
| Q1 24 | $2.9B | $753.0M |
| Q4 25 | $5.5B | $7.4B | ||
| Q3 25 | $6.4B | $7.5B | ||
| Q2 25 | $6.3B | $7.5B | ||
| Q1 25 | $6.1B | $7.4B | ||
| Q4 24 | $6.0B | $7.5B | ||
| Q3 24 | $5.9B | $7.5B | ||
| Q2 24 | $5.7B | $7.2B | ||
| Q1 24 | $5.5B | $8.0B |
| Q4 25 | 1.28× | 16.40× | ||
| Q3 25 | 0.74× | 14.96× | ||
| Q2 25 | 0.74× | 17.99× | ||
| Q1 25 | 0.72× | 7.18× | ||
| Q4 24 | 0.64× | 7.11× | ||
| Q3 24 | 0.62× | 6.20× | ||
| Q2 24 | 0.62× | 5.53× | ||
| Q1 24 | 0.65× | 5.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-86.3M | $137.0M |
| Free Cash FlowOCF − Capex | $-179.5M | $92.0M |
| FCF MarginFCF / Revenue | -21.8% | 6.9% |
| Capex IntensityCapex / Revenue | 11.3% | 3.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-439.9M | $51.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-86.3M | $137.0M | ||
| Q3 25 | $73.2M | $146.0M | ||
| Q2 25 | $133.5M | $93.0M | ||
| Q1 25 | $11.5M | $-112.0M | ||
| Q4 24 | $116.7M | $138.0M | ||
| Q3 24 | $163.1M | $139.0M | ||
| Q2 24 | $171.1M | $-620.0M | ||
| Q1 24 | $-321.3M | $-290.0M |
| Q4 25 | $-179.5M | $92.0M | ||
| Q3 25 | $-63.0M | $105.0M | ||
| Q2 25 | $-34.2M | $50.0M | ||
| Q1 25 | $-163.2M | $-196.0M | ||
| Q4 24 | $-86.8M | $29.0M | ||
| Q3 24 | $-27.1M | $63.0M | ||
| Q2 24 | $16.9M | $-693.0M | ||
| Q1 24 | $-463.7M | $-392.0M |
| Q4 25 | -21.8% | 6.9% | ||
| Q3 25 | -7.4% | 7.0% | ||
| Q2 25 | -3.9% | 3.1% | ||
| Q1 25 | -21.2% | -14.3% | ||
| Q4 24 | -11.2% | 2.1% | ||
| Q3 24 | -3.3% | 4.2% | ||
| Q2 24 | 2.1% | -44.6% | ||
| Q1 24 | -60.4% | -28.8% |
| Q4 25 | 11.3% | 3.4% | ||
| Q3 25 | 16.0% | 2.7% | ||
| Q2 25 | 19.3% | 2.7% | ||
| Q1 25 | 22.7% | 6.1% | ||
| Q4 24 | 26.3% | 8.0% | ||
| Q3 24 | 23.3% | 5.0% | ||
| Q2 24 | 19.4% | 4.7% | ||
| Q1 24 | 18.5% | 7.5% |
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | 3.17× | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | -10.33× | ||
| Q1 24 | -4.21× | -5.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
CC
| Titanium Technologies | $563.0M | 42% |
| Thermal And Specialized Solutions | $443.0M | 33% |
| Advanced Performance Materials | $312.0M | 23% |
| Other Non-Reportable Segment | $12.0M | 1% |
